Working with TipRanks
Follow Us
Stocks
ETFs
Options
Crypto
Currency
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Robert Hariri Insider Profile
4 Followers
Robert Hariri, Director at MedAvail Holdings, holds 42.25K shares in BioVie (Ticker: BIVI), holds 28.57M shares in Celularity (Ticker: CELU), holds 14.52K shares in CryoPort (Ticker: CYRX).
Profitable Transactions
4 out of 17 Profitable Transactions
Average Return
-29.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Robert Hariri holds in companies
Most Profitable Insider Trade
The most profitable trade made by Robert Hariri
Robert Hariri's Trading History
MedAvail Holdings
Apr 06, 2020
Director
Uninformative Buy
―
$268.57K
CryoPort
Sep 12, 2023
Director
Informative Sell
20.40K
$221.08K
Celularity
Oct 10, 2023
CEO, Director
Informative Buy
2.85M
$5.89M
BioVie
Dec 06, 2023
Director
Uninformative Buy
―
$73.52K
WaferGen Bio systems
Sep 20, 2011
―
Uninformative Buy
―
$1.10M
List of latest transactions for each holding click on a transaction to see Robert Hariri's performance on stock
You May Also Like
Robert Hariri insider profile FAQ
What is the percentage of profitable transactions made by Robert Hariri?
The percentage of profitable transactions made by Robert Hariri is 24%.
What is the average return per transaction made by Robert Hariri?
The average return per transaction made by Robert Hariri is -29.90%.
What stocks does Robert Hariri hold?
Robert Hariri holds: MDVL, CYRX, CELU, BIVI, WGBS stocks.
What was Robert Hariri’s latest transaction?
Robert Hariri latest transaction was an Uninformative Buy of ―.
What was Robert Hariri's most profitable transaction?
Robert Hariri’s most profitable transaction was an Informative Buy of CYRX stock on July 31, 2020. The return on the trade was 86.20%.
What is Robert Hariri's role in MedAvail Holdings?
Robert Hariri's role in MedAvail Holdings is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.